- Report
- April 2025
- 142 Pages
North America
From €3019EUR$3,450USD£2,625GBP
- Report
- April 2025
- 163 Pages
Europe
From €3019EUR$3,450USD£2,625GBP
- Report
- April 2025
- 161 Pages
Asia Pacific
From €3019EUR$3,450USD£2,625GBP
- Report
- October 2025
- 87 Pages
United States
From €4245EUR$4,850USD£3,690GBP
- Report
- October 2025
- 98 Pages
Middle East
From €4245EUR$4,850USD£3,690GBP
- Report
- August 2025
- 80 Pages
Africa, Middle East
From €3019EUR$3,450USD£2,625GBP
- Report
- August 2025
- 98 Pages
Asia Pacific
From €3457EUR$3,950USD£3,005GBP
- Report
- August 2025
- 101 Pages
Europe
From €3457EUR$3,950USD£3,005GBP
- Report
- August 2025
- 90 Pages
North America
From €3019EUR$3,450USD£2,625GBP
- Report
- June 2025
- 98 Pages
Europe
From €3457EUR$3,950USD£3,005GBP
- Report
- June 2025
- 88 Pages
North America
From €3019EUR$3,450USD£2,625GBP
- Report
- August 2019
- 264 Pages
Global
From €3496EUR$3,995USD£3,039GBP
- Report
- December 2024
- 332 Pages
Global
From €3673EUR$4,197USD£3,193GBP
- Report
- January 2025
- 363 Pages
Global
From €4200EUR$4,799USD£3,651GBP
- Report
- April 2022
- 116 Pages
Global
From €1137EUR$1,299USD£988GBP
- Report
- July 2022
- 263 Pages
Global
From €1800EUR$2,203USD£1,619GBP
- Report
- September 2023
- 249 Pages
Global
From €4703EUR$5,562USD£3,950GBP
- Report
- February 2025
- 315 Pages
Global
From €4200EUR$4,799USD£3,651GBP
- Report
- October 2021
- 145 Pages
Global
From €4200EUR$4,799USD£3,651GBP
- Report
- December 2022
- 437 Pages
Global
From €4703EUR$5,562USD£3,950GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more